Levomepromazine for nausea and vomiting in palliative care

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 5, 2015, Pages

  Cox, Lalage ^a   Darvill, Emily ^b   Dorman, Saskie ^c  

^a St Peter's Hospice   (United Kingdom)

^b CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^c POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOMEPROMAZINE; ANTIEMETIC AGENT;

CLINICAL ASSESSMENT; CLINICAL EVALUATION; COCHRANE LIBRARY; DRUG EFFICACY; EMBASE; HUMAN; INTERVENTION STUDY; MEDLINE; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; ADULT; FEMALE; NAUSEA; PREGNANCY; VOMITING;

ADULT; ANTIEMETICS; FEMALE; HUMANS; METHOTRIMEPRAZINE; NAUSEA; PALLIATIVE CARE; PREGNANCY; VOMITING;

EID: 84964696290     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009420.pub3     Document Type: Review

References (37)

1. Amesbury B, Alloway L, Hickmore E, Dewhurst G. High-dose levomepromazine (methotrimeprazine) to control nausea in carcinoid syndrome. Journal of Palliative Care 2004;20(2):117-8. 3395284
2. Baines M, Oliver DJ, Carter RL. Medical management of intestinal obstruction in patients with advanced malignant disease. Lancet 1985;2(8462):990-993. 3395286
3. Benze G, Alt-Epping B, Geyer A, Nauck F. Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients: a review. Der Schmerz 2012;26(5):500-14. 3395288
4. Dietz I, Schmitz A, Lampey I, Schulz C. Evidence for the use of levomepromazine for symptom control in the palliative care setting: a systematic review. BMC Palliative Care 2013;12. [DOI: doi:10.1186/1472-684X-12-2]3395290
5. Eisenchlas JH, Garrigue N, Junin M, De Simone GG. Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study. Palliative Medicine 2005;19(1):71-5. 3395292
6. Ell C, Konig H, Gutmann W, Domschke S, Domschke W. Prevention of cytostatic-induced vomiting. High-dosage metoclopramide versus an antiemetic combination in a controlled comparison [Prophylaxe von zytostatika-bedingtem Erbrechen. Hochdosiertes Metoclolpramid versus Antiemetika-Kombination im kontrollierten Vergleich]. Die Medizinische Welt 1983;34(35):945-8. 3395294
7. Gordon P, LeGrand SB, Walsh D. Nausea and vomiting in advanced cancer. European Journal of Pharmacology 2014;722:187-91. 3395296
8. Higi M, Niederle N, Schmidt C, Seeber S. Improved antiemetic treatment with levomepromazine [Verbesserte antiemetische Behandlung mit Levomepromazin bei zyotstatikabedingtem Erbrechen]. Deutsche Medizinische Wochenschrift 1980;105(22):794-5. 3395298
9. Kennett A, Hardy J, Shah S, A'Hern R. An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Supportive Care in Cancer 2005;13(9):715-21. 3395300
10. McCabe HL, Maraveyas A. Subcutaneous levomepromazine rescue (SLR) for high grade delayed chemotherapy-induced emesis (DCIE). Anticancer Research 2003;23(6D):5209-12. 3395302
11. Sgouros J, Neville-Webb H, Bunton S, Lind M, Maraveyas A. Levomepromazine versus dexamethasone with metoclopramide in the prevention of cisplatin induced delayed emesis. Preliminary results of a randomised study. British Journal of Cancer 2003;88:S68. 3395304
12. Twycross RG, Barkby DG, Hallwood PM. The use of low dose levomepromazine (methotrimeprazine) in the management of nausea and vomiting. Progress in Palliative Care 1997;5(2):49-53. 3395306
13. Hardy J. A study for participants with cancer who experience ongoing nausea, not related to their treatment, despite taking standard and usual medications, that studies the effectiveness of oral methotrimeprazine versus oral haloperidol. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12615000177550 (accessed 17 August 2015). 3395308
14. Hardy, J, Yates P. ACTRN12610000482066 [Randomised controlled trial: The effectiveness of alternative antiemetic therapies in patients with cancer and nausea not related to cancer therapy]. The Australian New Zealand Clinical Trials Registry (ANZCTR) 2010.
15. Bentley A, Boyd K. Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliative Medicine 2001;15(3):247-53.
16. Dahl SG, Strandjord RE, Sigfusson S. Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup. European Journal of Clincal Pharmacology 1977;11(4):305-10.
17. Davis MP, Hallerberg G, Palliative Medicine Study Group of the Multinational Association of Supportive Care in Cancer. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation. Journal of Pain and Symptom Management 2010;39(4):756-67.
18. Douglas C, Murtagh FE, Chambers EJ, Howse M, Ellershaw J. Symptom management for the adult patient dying with advanced kidney disease: a review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. Palliative Medicine 2009;23(2):103-10.
19. European Association for Palliative Care. Definition of palliative care (English). http://www.eapcnet.eu/Corporate/AbouttheEAPC/Definitionandaims.aspx (accessed 17 August 2015).
20. Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliative Medicine 2001;15(4):287-95.
21. Glare P, Pereira G, Kristjanson L, Stockler M, Tattersall M. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Supportive Care in Cancer 2004;12(6):432-40.
22. Grande GE, Todd CJ. Why are trials in palliative care so difficult?. Palliative Medicine 2000;14(1):69-74.
23. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
24. Hirst A, Sloan R. Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD003346]
25. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
26. Keeley PW. Nausea and vomiting in people with cancer and other chronic diseases. BMJ Clinical Evidence 2009;2009:2406.
27. Klinkenberg M, Willems DL, van der Wal G, Deeg DJ. Symptom burden in the last week of life. Journal of Pain and Symptom Management 2004;27(1):5-13.
28. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24.
29. Perkins P, Dorman S. Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006271.pub2]
30. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
31. Skinner J, Skinner A. Levomepromazine for nausea and vomiting in advanced cancer. Hospital Medicine 1999;60(8):568-70.
32. Stephenson J, Davies A. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Supportive Care in Cancer 2006;14(4):348-53.
33. Storrar J, Hitchens M, Platt T, Dorman S. Droperidol for treatment of nausea and vomiting in palliative care patients. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD006938.pub3]
34. Twycross R, Back I. Nausea and vomiting in advanced cancer. European Journal of Palliative Care 1998;5:39-45.
35. Twycross R, Wilcock A, Howard P (editors). Palliative Care Formulary. 5th Edition. Palliativedrugs.com Ltd, 2014.
36. Wee B, Hadley G, Derry S. How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews. BMC Palliative Care 2008;7. [doi:10.1186/1472-684X-7-13]
37. Darvill E, Dorman S, Perkins P. Levomepromazine for nausea and vomiting in palliative care. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD009420.pub2]